FLT3 and acute myeloid leukemia: We then asked whether the dominant effect of DNMT3A mutations seen in AMLDNMT3A/FLT3/NPM1 is observed in AML with either NPM1 or FLT3 mutations, which are important factors in risk stratification particularly for younger patients with CN-AML [26,27].